Bioceramics Market Report 2026

The bioceramics market size has grown strongly in recent years. It will grow from $4.39 billion in 2025 to $4.66 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increasing orthopedic surgical procedures, rising prevalence of bone and joint disorders, adoption of ceramic-based dental restorations, improvements in material science research, expansion of implant manufacturing capabilities.

The bioceramics market size is expected to see strong growth in the next few years. It will grow to $6 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing demand for minimally invasive implants, rising focus on patient-specific implant designs, expansion of regenerative medicine applications, growing investments in advanced biomaterials, technological advancements in ceramic processing. Major trends in the forecast period include increasing use of bioceramics in orthopedic implants, rising adoption of dental ceramic implants, growing demand for bioresorbable materials, expansion of customized implant solutions, enhanced focus on biocompatibility and longevity.

The increasing occurrence of cardiovascular diseases is anticipated to drive the expansion of the bioceramics market in the coming years. Cardiovascular diseases (CVDs) encompass a range of disorders that impact the heart and blood vessels. These conditions include coronary heart disease, cerebrovascular disease, peripheral arterial disease, and aortic atherosclerosis. Bioceramics are crucial in the management of cardiovascular diseases, as they are used as implantable materials in medical devices such as artificial heart valves and stents, enhancing biocompatibility and durability in cardiac procedures. For example, in September 2024, a report released by the British Heart Foundation (BHF), a UK-based charity dedicated to funding research and promoting awareness about heart and circulatory diseases, indicated that around 7.6 million people in the UK are living with heart and circulatory conditions. By 2030, this number is projected to grow by 1 million, and by 2040, it may increase by 2 million compared to current figures. Consequently, the rising incidence of cardiovascular diseases is fueling the growth of the bioceramics market.

Major companies in the bioceramics market are rolling out cutting-edge bioceramic solutions that boost clinical outcomes, manufacturing accuracy, and versatility across applications. A primary emphasis lies on innovative next-generation materials and production systems that broaden the potential of 3D-printed, customized patient implants. For example, in May 2024, Himed - a US-based biomaterials producer - and Lithoz - an Austrian firm specializing in ceramic 3D-printing technology - unveiled a new Bioceramics Center of Excellence to speed up the development and market entry of advanced bioceramic materials for healthcare uses. The companies state that this center will drive progress in high-performance calcium phosphate materials, advanced hydroxyapatite variants, and additive manufacturing processes tailored for orthopedic, dental, and regenerative medicine applications.

In July 2023, SHS Gesellschaft fur Beteiligungsmanagement mbH, a Germany-based independent private equity firm, acquired a majority stake in CAM Bioceramics for an undisclosed sum. This acquisition seeks to bolster and broaden SHS's presence in innovative calcium phosphate solutions within the medical sector. It is expected to drive the company's growth and success in the expanding bioceramics market. CAM Bioceramics, a Netherlands-based firm, produces bioceramics for use in medical and healthcare applications.

Major companies operating in the bioceramics market are Stryker Corporation, Zimmer Biomet, Kyocera Corporation, DSM Firmenich, Dentsply Sirona, Straumann Group, CeramTec, Morgan Advanced Materials, Saint Gobain, CamBioceramics, Bonesupport AB, Berkeley Advanced BioTypes, CaP Biomaterials, BIOMATCAN, Sagemax Bioceramics, Doceram Medical Ceramics, Jyoti Ceramic Industries, Ivoclar, GC Corporation, Tosoh Ceramics.

North America was the largest region in the bioceramics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioceramics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioceramics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the bioceramics market by increasing costs of imported raw ceramic powders, precision machining equipment, sintering furnaces, and quality testing instruments. Medical device manufacturers in North America and Europe are most affected due to reliance on imported high-purity materials, while Asia-Pacific faces higher production costs for export markets. These tariffs are elevating implant prices and slowing supply chains. At the same time, they are supporting domestic material production, regional processing facilities, and localized innovation in medical-grade ceramic materials.

The bioceramics market research report is one of a series of new reports that provides bioceramics market statistics, including bioceramics industry global market size, regional shares, competitors with a bioceramics market share, detailed bioceramics market segments, market trends and opportunities, and any further data you may need to thrive in the bioceramics industry. This bioceramics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

In August 2023, Coloplast A/S, a Denmark-based healthcare firm, acquired Kerecis - an Iceland-based company specializing in fish-skin-based wound care and tissue regeneration products - for an undisclosed amount, aiming to strengthen its offerings for chronic wounds, burns, and surgical wounds in response to growing demand for advanced solutions.

The primary categories of bioceramics consist of bioinert, bioactive, and bioresorbable types. Bioinert describes the characteristic of materials or compounds that exhibit no chemical reactivity. This group encompasses materials like aluminum oxide, zirconia, calcium phosphate, and more, applied in fields such as orthopedics, dental implants, biomedical devices, and others.

The bioceramics market consists of sales of bio-conductive ceramics, piezoelectric ceramics, radiopaque ceramics and composite bioceramics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.